Company intelligence / Profile preview

LEVY

Ownership: Private
Employees: ~50
Development stage: Other

Overview

LEVY Health provides a smart clinical decision support platform that enables early detection and personalized treatment recommendations for reproductive endocrine disorders. The system supports 152 diagnoses based on guidelines from ASRM, ESHRE, and ACOG. It streamlines medical history intake, automates lab orders/results interpretation, triages patients to appropriate treatments, and reduces time to diagnosis from years to weeks. The company has demonstrated improved diagnostic accuracy and faster patient access to care in real-world settings.

Therapeutic areas: EndocrinologyWomen's Health
Modalities: Non-pharmacological therapyDigital health platformVirtual care pathways
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on LEVY.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LEVY.

Explore the full profile